Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for C111.001

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates

(Topics flags: S Structure, A Assay, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Moore,P.K., Moore,E.E., Garner,R., Hansen,K., Barrett,C.D., Sauaia,A., Chandler,J., Janssen,W.J. and Moore,H.B.
    Coagulation factor XIII: An unrecognized regulator of fibrinolytic phenotypes in trauma-A potential link to protein MENT and cysteine cathepsin degradation of plasminogen
    J Trauma Acute Care Surg (2025) PubMed  Europe PubMed DOI
    2. 2023
  2. Desage,S., Leuci,A., Enjolras,N., Holle,L.A., Singh,S., Delavenne,X., Wolberg,A.S., Biswas,A. and Dargaud,Y.
    Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit
    Haemophilia (2023) 29, 1483-1489. PubMed  Europe PubMed DOI
  3. Osaki,T., Souri,M., Ozawa,T., Muraguchi,A. and Ichinose,A.
    Epitope analysis of human monoclonal antibodies from a patient with autoimmune factor XIII deficiency reveals their inhibitory mechanisms
    FEBS Lett (2023) 597, 1275-1289. PubMed  Europe PubMed DOI
    4. 2022
  4. De Simone,I., Baaten,C.C.F.M., Jandrot-Perrus,M., Gibbins,J.M., ten Cate,H., Heemskerk,J.W.M., Jones,C.I. and van der Meijden,P.E.J.
    Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
    Int J Mol Sci (2022) 23 PubMed  Europe PubMed DOI  PMC  EPMC
    5. 2021
  5. Leitner,M., Buchold,C., Pasternack,R., Binder,N.B. and Moore,G.W.
    Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity
    Int J Mol Sci (2021) 22 PubMed  Europe PubMed DOI  PMC  EPMC
    6. 2020
  6. Anokhin,B.A., Dean,W.L., Smith,K.A., Flick,M.J., Ariens,R.A.S., Philippou,H. and Maurer,M.C.
    Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A
    FEBS J (2020) 287, 452-464. PubMed  Europe PubMed DOI
  7. Csoban-Szabo,Z., Fesus,L. and Kiraly,R.
    Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity
    Anal Biochem (2020) , 113699-113699. PubMed  Europe PubMed DOI  A
  8. Leitner,M., Buchold,C., Pasternack,R. and Binder,N.B.
    Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity
    Anal Biochem (2020) , 113757-113757. PubMed  Europe PubMed DOI  A
  9. Pasternack,R., Buchold,C., Jahnig,R., Pelzer,C., Sommer,M., Heil,A., Florian,P., Nowak,G., Gerlach,U. and Hils,M.
    Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
    J Thromb Haemost (2020) 18, 191-200. PubMed  Europe PubMed DOI
  10. Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
    Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
    Clin Obes (2020) , e12397-e12397. PubMed  Europe PubMed DOI
  11. Schmitz,T., Bauml,C.A. and Imhof,D.
    Inhibitors of blood coagulation factor XIIIa
    Anal Biochem (2020) , 113708-113708. PubMed  Europe PubMed DOI  I
    12. 2017
  12. Anokhin,B.A., Stribinskis,V., Dean,W.L. and Maurer,M.C.
    Activation of factor XIII is accompanied by a change in oligomerization state
    FEBS J (2017) 284, 3849-3861. PubMed  Europe PubMed DOI
  13. Shubin,N.J., Glukhova,V.A., Clauson,M., Truong,P., Abrink,M., Pejler,G., White,N.J., Deutsch,G.H., Reeves,S.R., Vaisar,T., James,R.G. and Piliponsky,A.M.
    Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation
    J Allergy Clin Immunol (2017) 139, 323-334. PubMed  Europe PubMed DOI
    14. 2015
  14. Avery,C.A., Pease,R.J., Smith,K., Boothby,M., Buckley,H.M., Grant,P.J. and Fishwick,C.W.
    (+/-) cis-Bisamido epoxides: a novel series of potent FXIII-A inhibitors
    Eur J Med Chem (2015) 98, 49-53. PubMed  Europe PubMed DOI  I
    15. 2013
  15. Heil,A., Weber,J., Buchold,C., Pasternack,R. and Hils,M.
    Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael acceptor- and thioimidazol based blockers
    Thromb Res (2013) 131, e214-e222. PubMed  Europe PubMed DOI  I
  16. Schroeder,V. and Kohler,H.P.
    New developments in the area of factor XIII
    J Thromb Haemost (2013) 11, 234-244. PubMed  Europe PubMed DOI  V
    17. 2011
  17. Jadhav,M.A., Lucas,R.C., Goldsberry,W.N. and Maurer,M.C.
    Design of factor XIII V34X activation peptides to control ability to interact with thrombin mutants
    Biochim Biophys Acta (2011) 1814, 1955-1963. PubMed  Europe PubMed DOI
    18. 2002
  18. Fesus,L. and Piacentini,M.
    Transglutaminase 2: an enigmatic enzyme with diverse functions
    Trends Biochem Sci (2002) 27, 534-539. PubMed  Europe PubMed DOI
    19. 1999
  19. Makarova,K.S., Aravind,L. and Koonin,E.V.
    A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases
    Protein Sci (1999) 8, 1714-1719. PubMed  Europe PubMed DOI  PMC  EPMC
    20. 1998
  20. [YEAR:15-5-1998]Jenner,L., Husted,L., Thirup,S., Sottrup-Jensen,L. and Nyborg,J.
    Crystal structure of the receptor-binding domain of alpha2-macroglobulin
    Structure (15-5-1998) 6, 595-604. PubMed  Europe PubMed  S
    21. 1994
  21. Pedersen,L.C., Yee,V.C., Bishop,P.D., Le Trong,I., Teller,D.C. and Stenkamp,R.E.
    Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules
    Protein Sci (1994) 3, 1131-1135. PubMed  Europe PubMed DOI  PMC  EPMC  S
    22. 1993
  22. Lorand,L., Jeong,J.M., Radek,J.T. and Wilson,J.
    Human plasma factor XIII: subunit interactions and activation of zymogen
    Methods Enzymol (1993) 222, 22-35. PubMed  Europe PubMed DOI
    23. 1990
  23. Ichinose,A., Bottenus,R.E. and Davie,E.W.
    Structure of transglutaminases
    J Biol Chem (1990) 265, 13411-13414. PubMed  Europe PubMed  V
    24. 1988
  24. [YEAR:16-6-1988]Lynch,G.W. and Pfueller,S.L.
    Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease
    Thromb Haemost (16-6-1988) 59, 372-377. PubMed  Europe PubMed
    25. 1986
  25. Takahashi,N., Takahashi,Y. and Putnam,F.W.
    Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta
    Proc Natl Acad Sci U S A (1986) 83, 8019-8023. PubMed  Europe PubMed  PMC  EPMC
    26. 1983
  26. [YEAR:21-3-1983]Ichinose,A., Tamaki,T. and Aoki,N.
    Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin
    FEBS Lett (21-3-1983) 153, 369-371. PubMed  Europe PubMed DOI
    27. 1982
  27. [YEAR:25-12-1982]Tamaki,T. and Aoki,N.
    Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor
    J Biol Chem (25-12-1982) 257, 14767-14772. PubMed  Europe PubMed
    28. 1981
  28. Mortensen,S.B., Sottrup-Jensen,L., Hansen,H.F., Rider,D., Petersen,T.E. and Magnusson,S.
    Sequence location of a putative transglutaminase crosslinking site in human alpha2-macroglobulin
    FEBS Lett (1981) 129, 314-317. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use